Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin A for Thoracic Sympathetic Ganglion Block in CRPS
NCT06470581Not yet recruiting
- Sponsor
- Seoul National University
- Start
- Jul 2024
- Primary completion
- Apr 2026
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Randomised, double-blind trial of botulinum toxin type A in complex regional pain syndrome (CRPS) (2 arms), sponsored by Seoul National University. Primary endpoint: Changes in average pain intensity at 4 weeks. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
complex regional pain syndrome (CRPS)
Beyond the preview
Go deeper on NCT06470581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06470581.